Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
Fixed Capital/Sales

    Back to All Ratios
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   Fixed Capital/Sales(x) 1.331.191.221.261.21

What is the latest Fixed Capital/Sales ratio of PIRAMAL PHARMA ?

The latest Fixed Capital/Sales ratio of PIRAMAL PHARMA is 1.33 based on Mar2026 Consolidated results.
Year Fixed Capital/Sales
Mar20261.33
Mar20251.19
Mar20241.22
Mar20231.26
Mar20221.21

How is Fixed Capital/Sales of PIRAMAL PHARMA Trending?

Years Fixed Capital/Sales % Change
Mar2026 1.33
11.76
Mar2025 1.19
-2.46
Mar2024 1.22
-3.17
Mar2023 1.26
4.13
Mar2022 1.21 -

Other Financial Ratios of PIRAMAL PHARMA


Compare Fixed Capital/Sales ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹23,311.1 Cr 3.9% 5% -12.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,593.0 Cr 2% 6.7% 14.1% Stock Analytics
DIVIS LABORATORIES ₹179,737.0 Cr 3.5% 2.2% 0.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹164,290.0 Cr 4.6% 9.9% 41.5% Stock Analytics
CIPLA ₹117,327.0 Cr -0.3% 3.7% -2.3% Stock Analytics
DR REDDYS LABORATORIES ₹112,994.0 Cr 1.1% 5.9% 6.6% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

3.9%

5%

-12.5%

SENSEX

2.2%

5.1%

-7%


You may also like the below Video Courses